These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 15626487

  • 21. Loss of either CD4+ or CD8+ T cells does not affect the magnitude of protective immunity to an intracellular pathogen, Francisella tularensis strain LVS.
    Yee D, Rhinehart-Jones TR, Elkins KL.
    J Immunol; 1996 Dec 01; 157(11):5042-8. PubMed ID: 8943413
    [Abstract] [Full Text] [Related]

  • 22. Susceptibility of various mouse strains to systemically- or aerosol-initiated tularemia by virulent type A Francisella tularensis before and after immunization with the attenuated live vaccine strain of the pathogen.
    Shen H, Chen W, Conlan JW.
    Vaccine; 2004 Jun 02; 22(17-18):2116-21. PubMed ID: 15149767
    [Abstract] [Full Text] [Related]

  • 23. Toll-like receptors and innate antiviral responses.
    Vaidya SA, Cheng G.
    Curr Opin Immunol; 2003 Aug 02; 15(4):402-7. PubMed ID: 12900271
    [Abstract] [Full Text] [Related]

  • 24. Nature of protective immunity to Francisella tularensis.
    Tärnvik A.
    Rev Infect Dis; 1989 Aug 02; 11(3):440-51. PubMed ID: 2665002
    [Abstract] [Full Text] [Related]

  • 25. The membrane form of tumor necrosis factor is sufficient to mediate partial innate immunity to Francisella tularensis live vaccine strain.
    Cowley SC, Goldberg MF, Ho JA, Elkins KL.
    J Infect Dis; 2008 Jul 15; 198(2):284-92. PubMed ID: 18593295
    [Abstract] [Full Text] [Related]

  • 26. Toll-like receptors and other links between innate and acquired alloimmunity.
    Goldstein DR.
    Curr Opin Immunol; 2004 Oct 15; 16(5):538-44. PubMed ID: 15341996
    [Abstract] [Full Text] [Related]

  • 27. Specific antibodies protect gamma-irradiated mice against Francisella tularensis infection.
    Kubelkova K, Krocova Z, Balonova L, Pejchal J, Stulik J, Macela A.
    Microb Pathog; 2012 Oct 15; 53(5-6):259-68. PubMed ID: 22841607
    [Abstract] [Full Text] [Related]

  • 28. Innate immunity: from lymphocyte mitogens to Toll-like receptors and back.
    Coutinho A, Poltorack A.
    Curr Opin Immunol; 2003 Dec 15; 15(6):599-602. PubMed ID: 14630190
    [Abstract] [Full Text] [Related]

  • 29. A novel role for B cells in early protective immunity to an intracellular pathogen, Francisella tularensis strain LVS.
    Culkin SJ, Rhinehart-Jones T, Elkins KL.
    J Immunol; 1997 Apr 01; 158(7):3277-84. PubMed ID: 9120284
    [Abstract] [Full Text] [Related]

  • 30. The ability of CpG oligonucleotides to protect mice against Francisella tularensis live vaccine strain but not fully virulent F. tularensis subspecies holarctica is reflected in cell-based assays.
    Rees DG, Hartley MG, Green M, Lukaszewski RA, Griffin KF, Atkins HS, Lyons R, Krieg AM, Titball RW.
    Microb Pathog; 2013 Oct 01; 63():16-8. PubMed ID: 23707360
    [Abstract] [Full Text] [Related]

  • 31. Host resistance to the LVS strain of Francisella tularensis in BCG vaccinated mice.
    Taplits MS, Myrvik QN.
    J Reticuloendothel Soc; 1977 Oct 01; 22(4):297-308. PubMed ID: 411926
    [No Abstract] [Full Text] [Related]

  • 32. Antimicrobial activity of mosquito cecropin peptides against Francisella.
    Kaushal A, Gupta K, Shah R, van Hoek ML.
    Dev Comp Immunol; 2016 Oct 01; 63():171-80. PubMed ID: 27235883
    [Abstract] [Full Text] [Related]

  • 33. Innate immunity, Toll-like receptors and host response to infection.
    Doherty TM, Arditi M.
    Pediatr Infect Dis J; 2005 Jul 01; 24(7):643-4. PubMed ID: 15999009
    [No Abstract] [Full Text] [Related]

  • 34. Cytokines in innate host defense in the lung.
    Strieter RM, Belperio JA, Keane MP.
    J Clin Invest; 2002 Mar 01; 109(6):699-705. PubMed ID: 11901175
    [No Abstract] [Full Text] [Related]

  • 35. Subversion of innate immune responses by Francisella involves the disruption of TRAF3 and TRAF6 signalling complexes.
    Putzova D, Panda S, Härtlova A, Stulík J, Gekara NO.
    Cell Microbiol; 2017 Nov 01; 19(11):. PubMed ID: 28745813
    [Abstract] [Full Text] [Related]

  • 36. Toll-like receptor 4 is not involved in host defense against respiratory tract infection with Sendai virus.
    van der Sluijs KF, van Elden L, Nijhuis M, Schuurman R, Florquin S, Jansen HM, Lutter R, van der Poll T.
    Immunol Lett; 2003 Oct 31; 89(2-3):201-6. PubMed ID: 14556979
    [Abstract] [Full Text] [Related]

  • 37. Toll-like receptor 4 plays no role in susceptibility of mice to Mycobacterium tuberculosis infection.
    Shim TS, Turner OC, Orme IM.
    Tuberculosis (Edinb); 2003 Oct 31; 83(6):367-71. PubMed ID: 14623167
    [Abstract] [Full Text] [Related]

  • 38. Toll-like receptors in health and disease: complex questions remain.
    Sabroe I, Read RC, Whyte MK, Dockrell DH, Vogel SN, Dower SK.
    J Immunol; 2003 Aug 15; 171(4):1630-5. PubMed ID: 12902458
    [No Abstract] [Full Text] [Related]

  • 39. Cutting into innate immunity.
    Winoto A.
    Nat Immunol; 2004 Jun 15; 5(6):563-4. PubMed ID: 15164013
    [No Abstract] [Full Text] [Related]

  • 40. Influence of innate immune responses on autoimmunity.
    Tenner AJ.
    Autoimmunity; 2004 Mar 15; 37(2):83-4. PubMed ID: 15293877
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.